About N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide
N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide (PubChem CID 122392307) has the molecular formula C18H12BrClN4O2S
and a molecular weight of 463.74 g/mol. Its IUPAC name is N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide.
Analyze N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide?
The IUPAC name of N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide (CID 122392307) is N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide.
What is the SMILES notation for N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide?
The canonical SMILES for N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide is O=S(=O)(Nc1c(-c2ccccc2)nc2ncc(Br)cn12)c1ccc(Cl)cc1.
What is the InChIKey of N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide?
The InChIKey is XBXRAUCYNUTSQR-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H12BrClN4O2S/c19-13-10-21-18-22-16(12-4-2-1-3-5-12)17(24(18)11-13)23-27(25,26)15-8-6-14(20)7-9-15/h1-11,23H.
What are the key properties of N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide?
N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide has a molecular weight of 463.74 g/mol, XLogP of 4.61, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-(6-bromo-2-phenylimidazo[1,2-a]pyrimidin-3-yl)-4-chlorobenzenesulfonamide is sourced from PubChem (CID 122392307), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).